Study of semaglutide to help veterans drink less alcohol
Treatments studied
Part of Mental health clinical trials.
This study tests whether a weekly medicine called semaglutide can help veterans who drink heavily reduce their alcohol intake. If you're a veteran and want to cut down on drinking, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a veteran.
- Drink at a high or very high risk level in the past month.
- Have a current diagnosis of moderate or severe alcohol use disorder.
- Want to reduce your alcohol consumption.
- Have no serious liver, pancreas, or other medical conditions that could make the medicine unsafe.
- Not be taking certain diabetes medicines or alcohol treatment medicines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a weekly injection (a GLP-1 medication similar to semaglutide) can help people with obesity and fatty liver reduce their alcohol intake and improve liver health. It may be an option if you drink more than moderate amounts and have fatty liver.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
This study tests if a medication called semaglutide (used for diabetes and weight loss) can help reduce alcohol craving and drinking. It also looks at how the drug affects stress hormones and metabolism, which may help you drink less and lose weight.
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.
This Phase 2 study tests how semaglutide (a diabetes medication also used for weight) affects fatty liver and the liver’s response to sugar. It may help people with non-alcoholic fatty liver disease understand whether the drug improves liver fat and related changes.
This study tests whether an oral medication called semaglutide can help people with type 2 diabetes, fatty liver, and kidney problems. It aims to see if it can improve kidney function and liver health.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.